What is B3 Sciences?
B3 Sciences specializes in blood flow restriction (BFR) bands, innovative devices engineered to optimize muscle hypertrophy, accelerate fat loss, and enhance overall physical well-being. Their BFR technology is tailored for a diverse clientele, including professional athletes, military personnel, senior citizens, and individuals undergoing physical rehabilitation. By enabling more efficient workouts, B3 Sciences' products allow users to achieve significant results in reduced exercise durations. The company further supports its user base through comprehensive BFR coaching programs and specialized nutrition products, fostering a holistic approach to fitness and health.
How much funding has B3 Sciences raised?
B3 Sciences has raised a total of $78K across 1 funding round:
Debt
$78K
Debt (2021): $78K with participation from PPP
What's next for B3 Sciences?
With substantial expansion capital secured at a significant Series B/C stage, B3 Sciences is strategically positioned for accelerated growth. This latest investment is anticipated to fuel further product development, enhance market penetration, and potentially expand into new therapeutic or performance-enhancement verticals. The company's focus on evidence-based BFR technology and a comprehensive support ecosystem suggests a continued commitment to innovation and user-centric solutions in the burgeoning health and wellness market.
See full B3 Sciences company page
